威健股份有限公司 Approved
最後更新時間 2025/08/03 , 06:17 PM
最後更新時間 2025/08/03 , 06:17 PM
負責人
Chen,Gui-Hong
統一編號
80158777
成立日期
2003/01/30
資本額
NT$600,000,000
實收資本額
NT$233,042,480
股票代號
6661
電話
02-2655-7569
地址
12F, No. 3, Park St., Nangang Dist., Taipei City, 115, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Chen,Gui-Hong Chairman 2.10%
Chen,Fu-Qian Director 30.31% HanGii Co., Ltd.
Lin,Jia-Qi Director 1.25%
Lin,Yi-Xing Director 1.40%
Wu,Zhao-Yuan Independent Director
Yang,Yun-Cheng Independent Director
Li,Yan-Ling Independent Director
營業項目
  • Retail Sale of Pharmaceutical and Medical Goods in Specialized Stores(475199)
  • Wholesale of Chemical Materials and Chemical Products(462099)
  • 公司歷程
  • Change Capital to 600,000,000
    2023/05/29
  • Change Person in Charge to Chen,Gui-Hong
    2023/05/29
  • Change Capital to 300,000,000
    2015/09/01
  • Change Capital to 150,000,000
    2014/05/29
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 77,891 322,548 280,547
    Operating cost 46,786 186,710 160,831
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 31,105 135,838 119,716
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 31,105 135,838 119,716
    Operating expenses 36,496 136,692 123,975
    Other gain (loss), net - - -
    Operating profit (loss) -5,391 -854 -4,259
    Non-operating income and expenses 480 2,104 1,227
    Net profit (loss) before tax -4,911 1,250 -3,032
    Income tax expense (benefits) -109 544 114
    Net profit (loss) of ongoing business for the current period -4,802 706 -3,146
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -4,802 706 -3,146
    Other comprehensive profit (loss), net 96 -5,230 -4,827
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -4,706 -4,524 -7,973
    Net profit (loss) attributable to owners of parent company -4,565 1,107 -2,648
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -237 -401 -498
    Comprehensive profit (loss) attributable to owners of parent company -4,469 -4,123 -7,475
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -237 -401 -498
    Basic earnings per share (yuan) 0 0 0
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -6,450 56,076 -366
    Net cash inflows (outflows) from investing activities 19,793 -45,193 5,997
    Net cash inflow (outflow) from financing activities 20,260 -25,518 23,908
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period 33,603 -14,635 29,539
    Beginning balance of cash and cash equivalents 173,495 188,130 158,591
    Ending balance of cash and cash equivalents 207,098 173,495 188,130
    項目 2025 2024 2023
    Current asset 331,658 320,221 306,278
    Non-current asset 201,915 208,027 241,886
    Total asset 533,573 528,248 548,164
    Current liability 132,622 136,588 127,942
    Non-current liability 112,863 95,914 119,952
    Total liability 245,485 232,502 247,894
    share capital 233,043 233,043 233,043
    Equity - secruity token - - -
    capital reserve 50,932 50,860 50,860
    retained earning 15,399 20,619 19,512
    Other equity -15,860 -16,611 -11,381
    Treasury stock - - -
    Total equity attributable to owners of parent company 283,514 287,911 292,034
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 4,574 7,835 8,236
    Total Equity 288,088 295,746 300,270
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 12 12 12
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • CytoScan
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。